Princess Margaret Cancer Centre at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Princess Margaret Cancer Centre brings 2 presentations to ASH 2026 in New Orleans. Its program spans RNA-binding proteins in leukemia, Hodgkin lymphoma biology and guideline care for light-chain amyloidosis. It also looks at how macrophages and the tumor cells of Hodgkin lymphoma interact to evade the immune system and resist therapy.
| Organization | ASH 2026 Attendance |
|---|---|
Princess Margaret Cancer Centre Toronto, Canada | |
Cancer centre of University Health Network in Toronto, Canada, for cancer care, research and education. | Talk RNA Binding Proteins in Hematopoiesis and Leukemia Proteins that bind RNA control normal and leukemic blood formation, and mutations in untranslated parts of messages can rewire those programs in leukemia. Talk Macrophage–HRS Cell Crosstalk Driving Immune Evasion and Therapy Resistance in Hodgkin Lymphoma Single-cell and spatial studies of how macrophages help the rare malignant cells of classic Hodgkin lymphoma survive, evade immunity and resist treatment. Session Clinical Practice Guideline on the Treatment of Light-Chain Amyloidosis Guideline advice for light-chain amyloidosis on first-line therapy, stem cell transplant, response-adapted treatment, and relapsed disease. |
Instantly find 20 buyers from Princess Margaret Cancer Centre
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction